Literature DB >> 24010662

Identification of fibril-like tertiary contacts in soluble monomeric α-synuclein.

Santiago Esteban-Martín1, Jordi Silvestre-Ryan, Carlos W Bertoncini, Xavier Salvatella.   

Abstract

Structural conversion of the presynaptic, intrinsically disordered protein α-synuclein into amyloid fibrils underlies neurotoxicity in Parkinson's disease. The detailed mechanism by which this conversion occurs is largely unknown. Here, we identify a discrete pattern of transient tertiary interactions in monomeric α-synuclein involving amino acid residues that are, in the fibrillar state, part of β-strands. Importantly, this pattern of pairwise interactions does not correspond to that found in the amyloid state. A redistribution of this network of fibril-like contacts must precede aggregation into the amyloid structure.
Copyright © 2013 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24010662      PMCID: PMC3762368          DOI: 10.1016/j.bpj.2013.07.044

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  64 in total

1.  Evidence for a partially folded intermediate in alpha-synuclein fibril formation.

Authors:  V N Uversky; J Li; A L Fink
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

2.  A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly.

Authors:  B I Giasson; I V Murray; J Q Trojanowski; V M Lee
Journal:  J Biol Chem       Date:  2000-11-01       Impact factor: 5.157

3.  Im7 folding mechanism: misfolding on a path to the native state.

Authors:  Andrew P Capaldi; Colin Kleanthous; Sheena E Radford
Journal:  Nat Struct Biol       Date:  2002-03

4.  Solvent-induced collapse of alpha-synuclein and acid-denatured cytochrome c.

Authors:  A S Morar; A Olteanu; G B Young; G J Pielak
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

5.  Low-populated folding intermediates of Fyn SH3 characterized by relaxation dispersion NMR.

Authors:  Dmitry M Korzhnev; Xavier Salvatella; Michele Vendruscolo; Ariel A Di Nardo; Alan R Davidson; Christopher M Dobson; Lewis E Kay
Journal:  Nature       Date:  2004-07-29       Impact factor: 49.962

6.  Structural interpretation of paramagnetic relaxation enhancement-derived distances for disordered protein states.

Authors:  Debabani Ganguly; Jianhan Chen
Journal:  J Mol Biol       Date:  2009-05-15       Impact factor: 5.469

7.  Residual structure and dynamics in Parkinson's disease-associated mutants of alpha-synuclein.

Authors:  R Bussell; D Eliezer
Journal:  J Biol Chem       Date:  2001-10-04       Impact factor: 5.157

8.  Conformational properties of alpha-synuclein in its free and lipid-associated states.

Authors:  D Eliezer; E Kutluay; R Bussell; G Browne
Journal:  J Mol Biol       Date:  2001-04-06       Impact factor: 5.469

Review 9.  Molecular pathways of neurodegeneration in Parkinson's disease.

Authors:  Ted M Dawson; Valina L Dawson
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

10.  A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins.

Authors:  Robert Bussell; David Eliezer
Journal:  J Mol Biol       Date:  2003-06-13       Impact factor: 5.469

View more
  15 in total

1.  Transient β-hairpin formation in α-synuclein monomer revealed by coarse-grained molecular dynamics simulation.

Authors:  Hang Yu; Wei Han; Wen Ma; Klaus Schulten
Journal:  J Chem Phys       Date:  2015-12-28       Impact factor: 3.488

2.  Structural insights into amyloid oligomers of the Parkinson disease-related protein α-synuclein.

Authors:  J Ignacio Gallea; M Soledad Celej
Journal:  J Biol Chem       Date:  2014-08-20       Impact factor: 5.157

3.  Molecular details of α-synuclein membrane association revealed by neutrons and photons.

Authors:  Zhiping Jiang; Sara K Hess; Frank Heinrich; Jennifer C Lee
Journal:  J Phys Chem B       Date:  2015-04-01       Impact factor: 2.991

4.  Effect of an Amyloidogenic SARS-COV-2 Protein Fragment on α-Synuclein Monomers and Fibrils.

Authors:  Asis K Jana; Chance W Lander; Andrew D Chesney; Ulrich H E Hansmann
Journal:  J Phys Chem B       Date:  2022-05-17       Impact factor: 3.466

5.  The neural chaperone proSAAS blocks α-synuclein fibrillation and neurotoxicity.

Authors:  Timothy S Jarvela; Hoa A Lam; Michael Helwig; Nikolai Lorenzen; Daniel E Otzen; Pamela J McLean; Nigel T Maidment; Iris Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-25       Impact factor: 11.205

6.  A maximum entropy approach to the study of residue-specific backbone angle distributions in α-synuclein, an intrinsically disordered protein.

Authors:  Alexey B Mantsyzov; Alexander S Maltsev; Jinfa Ying; Yang Shen; Gerhard Hummer; Ad Bax
Journal:  Protein Sci       Date:  2014-07-22       Impact factor: 6.725

7.  Insights into the molecular mechanism of amyloid filament formation: Segmental folding of α-synuclein on lipid membranes.

Authors:  Leif Antonschmidt; Rıza Dervişoğlu; Vrinda Sant; Kumar Tekwani Movellan; Ingo Mey; Dietmar Riedel; Claudia Steinem; Stefan Becker; Loren B Andreas; Christian Griesinger
Journal:  Sci Adv       Date:  2021-05-14       Impact factor: 14.136

Review 8.  Information flow and protein dynamics: the interplay between nuclear magnetic resonance spectroscopy and molecular dynamics simulations.

Authors:  Nina Pastor; Carlos Amero
Journal:  Front Plant Sci       Date:  2015-05-05       Impact factor: 5.753

9.  X-ray Crystallographic Structure of Oligomers Formed by a Toxic β-Hairpin Derived from α-Synuclein: Trimers and Higher-Order Oligomers.

Authors:  Patrick J Salveson; Ryan K Spencer; James S Nowick
Journal:  J Am Chem Soc       Date:  2016-03-23       Impact factor: 15.419

10.  Phosphorylation induces distinct alpha-synuclein strain formation.

Authors:  Meng-Rong Ma; Zhi-Wen Hu; Yu-Fen Zhao; Yong-Xiang Chen; Yan-Mei Li
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.